Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

Stock Information for New Horizon Aircraft Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About New Horizon Aircraft Ltd.

Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions Reports First Quarter 2025 Financial Results
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
Emergent BioSolutions Announces Stock Repurchase Program
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.